OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-11
DOI
10.3389/fcell.2021.570898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
- (2019) James R. Birtley et al. Nature Communications
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
- (2017) Elisa Zanini et al. MOLECULAR CANCER THERAPEUTICS
- A DNA methylation map of human cancer at single base-pair resolution
- (2017) E Vidal et al. ONCOGENE
- Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
- (2017) Bi Wang et al. Oncology Letters
- The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
- (2017) Lele Song et al. Scientific Reports
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- Application of Multiplex Nested Methylated Specific PCR in Early Diagnosis of Epithelial Ovarian Cancer
- (2015) Bi Wang et al. Asian Pacific Journal of Cancer Prevention
- Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
- (2015) Garth H. Rauscher et al. BMC CANCER
- Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer
- (2015) B.L. Xing et al. GENETICS AND MOLECULAR RESEARCH
- Detection of Circulating Methylated Opioid Binding Protein/Cell Adhesion Molecule-Like Gene as a Biomarker for Ovarian Carcinoma
- (2014) Feng Zhou et al. Clinical Laboratory
- Associated Analysis of DNA Methylation for Cancer Detection Using CCP-Based FRET Technique
- (2013) Jiangyan Zhang et al. ANALYTICAL CHEMISTRY
- Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival
- (2013) Feng Zhou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- New Roles Opined for OPCML: Figure 1.
- (2012) Sherry Y. Wu et al. Cancer Discovery
- The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer
- (2012) Arthur B. McKie et al. Cancer Discovery
- DNA methylation signatures for breast cancer classification and prognosis
- (2012) Moshe Szyf Genome Medicine
- CpG-island methylation study of liver fluke-related cholangiocarcinoma
- (2011) R Sriraksa et al. BRITISH JOURNAL OF CANCER
- Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma
- (2011) Sara Duarte-Pereira et al. EUROPEAN JOURNAL OF CANCER
- OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
- (2008) Yan Cui et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started